TrialBlood cancer journal2014

Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia.

G Zugmaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.